These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30625381)

  • 1. Deficiency of metabolite sensing receptor HCA2 impairs the salutary effect of niacin in hemorrhagic shock.
    Subramani K; Chu X; Warren M; Lee M; Lu S; Singh N; Raju R
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):688-695. PubMed ID: 30625381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Niacin protects against abdominal aortic aneurysm formation via GPR109A independent mechanisms: role of NAD+/nicotinamide.
    Horimatsu T; Blomkalns AL; Ogbi M; Moses M; Kim D; Patel S; Gilreath N; Reid L; Benson TW; Pye J; Ahmadieh S; Thompson A; Robbins N; Mann A; Edgell A; Benjamin S; Stansfield BK; Huo Y; Fulton DJ; Agarwal G; Singh N; Offermanns S; Weintraub NL; Kim HW
    Cardiovasc Res; 2020 Dec; 116(14):2226-2238. PubMed ID: 31710686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide mononucleotide preserves mitochondrial function and increases survival in hemorrhagic shock.
    Sims CA; Guan Y; Mukherjee S; Singh K; Botolin P; Davila A; Baur JA
    JCI Insight; 2018 Sep; 3(17):. PubMed ID: 30185676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Niacin receptor activation improves human microvascular endothelial cell angiogenic function during lipotoxicity.
    Hughes-Large JM; Pang DK; Robson DL; Chan P; Toma J; Borradaile NM
    Atherosclerosis; 2014 Dec; 237(2):696-704. PubMed ID: 25463108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages.
    Feingold KR; Moser A; Shigenaga JK; Grunfeld C
    J Lipid Res; 2014 Dec; 55(12):2501-8. PubMed ID: 25320346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel treatment target for Parkinson's disease.
    Wakade C; Chong R
    J Neurol Sci; 2014 Dec; 347(1-2):34-8. PubMed ID: 25455298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of GPR109A in Parkinson's disease.
    Wakade C; Chong R; Bradley E; Thomas B; Morgan J
    PLoS One; 2014; 9(10):e109818. PubMed ID: 25329911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Niacin stimulates adiponectin secretion through the GPR109A receptor.
    Plaisance EP; Lukasova M; Offermanns S; Zhang Y; Cao G; Judd RL
    Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E549-58. PubMed ID: 19141678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing.
    Benyó Z; Gille A; Kero J; Csiky M; Suchánková MC; Nüsing RM; Moers A; Pfeffer K; Offermanns S
    J Clin Invest; 2005 Dec; 115(12):3634-40. PubMed ID: 16322797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Niacin and Butyrate: Nutraceuticals Targeting Dysbiosis and Intestinal Permeability in Parkinson's Disease.
    Karunaratne TB; Okereke C; Seamon M; Purohit S; Wakade C; Sharma A
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential tissue and ligand-dependent signaling of GPR109A receptor: implications for anti-atherosclerotic therapeutic potential.
    Gaidarov I; Chen X; Anthony T; Maciejewski-Lenoir D; Liaw C; Unett DJ
    Cell Signal; 2013 Oct; 25(10):2003-16. PubMed ID: 23770183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis.
    Singh N; Gurav A; Sivaprakasam S; Brady E; Padia R; Shi H; Thangaraju M; Prasad PD; Manicassamy S; Munn DH; Lee JR; Offermanns S; Ganapathy V
    Immunity; 2014 Jan; 40(1):128-39. PubMed ID: 24412617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of GPR109a Signaling in Niacin Induced Effects on Fed and Fasted Hepatic Metabolism.
    Geisler CE; Miller KE; Ghimire S; Renquist BJ
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated niacin receptor HCA2 inhibits chemoattractant-mediated macrophage migration via Gβγ/PKC/ERK1/2 pathway and heterologous receptor desensitization.
    Shi Y; Lai X; Ye L; Chen K; Cao Z; Gong W; Jin L; Wang C; Liu M; Liao Y; Wang JM; Zhou N
    Sci Rep; 2017 Feb; 7():42279. PubMed ID: 28186140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets.
    Chen L; So WY; Li SY; Cheng Q; Boucher BJ; Leung PS
    Mol Cell Endocrinol; 2015 Mar; 404():56-66. PubMed ID: 25622782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Niacin Ameliorates Neuro-Inflammation in Parkinson's Disease via GPR109A.
    Giri B; Belanger K; Seamon M; Bradley E; Purohit S; Chong R; Morgan JC; Baban B; Wakade C
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Niacin fine-tunes energy homeostasis through canonical GPR109A signaling.
    Ye L; Cao Z; Lai X; Wang W; Guo Z; Yan L; Wang Y; Shi Y; Zhou N
    FASEB J; 2019 Apr; 33(4):4765-4779. PubMed ID: 30596513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Niacin receptor GPR109A inhibits insulin secretion and is down-regulated in type 2 diabetic islet beta-cells.
    Wang N; Guo DY; Tian X; Lin HP; Li YP; Chen SJ; Fu YC; Xu WC; Wei CJ
    Gen Comp Endocrinol; 2016 Oct; 237():98-108. PubMed ID: 27570060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression.
    Lauring B; Taggart AK; Tata JR; Dunbar R; Caro L; Cheng K; Chin J; Colletti SL; Cote J; Khalilieh S; Liu J; Luo WL; Maclean AA; Peterson LB; Polis AB; Sirah W; Wu TJ; Liu X; Jin L; Wu K; Boatman PD; Semple G; Behan DP; Connolly DT; Lai E; Wagner JA; Wright SD; Cuffie C; Mitchel YB; Rader DJ; Paolini JF; Waters MG; Plump A
    Sci Transl Med; 2012 Aug; 4(148):148ra115. PubMed ID: 22914621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid.
    Pike NB
    J Clin Invest; 2005 Dec; 115(12):3400-3. PubMed ID: 16322787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.